The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians

Hypertension Research

Volumn 27, Issue 9, 2004, Pages 663-667

  Heux, Stephanie ^a   Morin, Fabien ^a   Lea, Rod A ^a,b   Ovcaric, Micky ^a   Tajouri, Lofti ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Association; Body mass index; Homocysteine; Hypertension; Methylenetetrahydrofolate reductase gene

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTEINE; HOMOCYSTEINE; TYROSINE;

ADULT; ALLELE; ARTICLE; AUSTRALIA; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RISK FACTORS;

EID: 8844244056     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.663     Document Type: Article

References (16)

1. O'Shaughnessy KM: The genetics of essential hypertension. Br J Clin Pharmacol 2001; 51: 5-11.
2. Ward R: Familial aggregation and genetic epidemiology of blood pressure, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, 1995, pp 81-100.
3. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
4. Slager SL, Schaid DJ: Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet 2001; 68: 1457-1462.
5. Nakayama T, Soma M, Haketa A, et al: Haplotype analysis of the prostacyclin synthase gene and essential hypertension. Hypertens Res 2003; 26: 553-557.
6. Benjafield AV, Iwai N, Ishikawa K, Wang WY, Morris BJ: Overweight, but not hypertension, is associated with SAH polymorphisms in Caucasians with essential hypertension. Hypertens Res 2003; 26 591-595.
7. Wang B, Zhou X, Dang A, Liu G, He R: Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator and the risk of hypertension in a Chinese Han population. Hypertens Res 2002; 25 949-953.
8. Perry IJ: Homocysteine, hypertension and stroke. J Hum Hypertens 1999; 13: 289-293.
9. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202.
10. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
11. Goyette P, Summer JS, Milos R, et al: Human methylenetetrahydrofolate reductase isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7: 195-200.
12. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A, Alamo-Santana F: Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 2003; 21: 1649-1655.
13. Inamoto N, Katsuya T, Kokubo Y, et al: Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 2003; 34: 1628-1633.
14. Friend LR, Morris BJ, Gaffney PT, Griffiths LR: Examination of the role of nitric oxide synthase and renal kallikrein as candidate genes for essential hypertension. Clin Exp Pharmacol Physiol 1996; 23: 564-566.
15. Benes P, Kankova K, Muzik J, et al: Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. J Mol Genet Metab 2001; 73: 188-195.
16. Rosenberg N, Murata M, Ikeda Y, et al: The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002; 70: 758-762.